Singh Harkirat, Siddiqui Ali A
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA.
Semin Oncol. 2015 Feb;42(1):59-69. doi: 10.1053/j.seminoncol.2014.12.006. Epub 2014 Dec 9.
Computed tomography (CT) is the primary imaging modality for initial evaluation of pancreatic cancer (PC). Endoscopic ultrasound (EUS) has a higher sensitivity for detection of PC and is better especially for lesions<3 cm. It should be the next step if the CT scan is indeterminate, or negative in the presence of high suspicion of PC based on clinical and laboratory data. EUS-guided fine-needle aspiration (FNA) should be performed for lesions found on EUS after negative or indeterminate CT, for borderline resectable pancreatic cancer (BRPC) and unresectable cancer, or if the patient is being considered for neoadjuvant or palliative chemotherapy. EUS elastography and contrast-enhanced harmonic EUS are new and promising EUS technologies that may detect lesions missed by other modalities and may help guide EUS-FNA to target lesions.
计算机断层扫描(CT)是胰腺癌(PC)初始评估的主要影像学检查方法。内镜超声(EUS)对PC的检测具有更高的敏感性,尤其对于<3 cm的病变效果更佳。如果CT扫描结果不确定,或者根据临床和实验室数据高度怀疑PC但CT结果为阴性,则应进行EUS检查。对于CT检查结果为阴性或不确定后在EUS上发现的病变、临界可切除胰腺癌(BRPC)和不可切除癌,或者如果患者正在考虑进行新辅助或姑息化疗,均应进行EUS引导下细针穿刺活检(FNA)。EUS弹性成像和对比增强谐波EUS是新的且有前景的EUS技术,它们可能检测出其他检查方法遗漏的病变,并可能有助于引导EUS-FNA针对目标病变。